Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
2 Biotech Stocks to Buy Right Now
09:31am, Sunday, 19'th Sep 2021
They both have great growth prospects.
Twist Bioscience, Boehringer Ingelheim Joins Forces For Antibody Research Programs
10:52am, Thursday, 09'th Sep 2021
Twist Bioscience Corporation (NASDAQ: TWST) has announced a broad-based research collaboration with Boehringer Ingelheim International GmbH. The collaboration will use Twist's proprietary antibody
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
09:56am, Thursday, 09'th Sep 2021
SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DN
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
08:00am, Wednesday, 08'th Sep 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery
12:15pm, Wednesday, 18'th Aug 2021
Twist Bioscience Corporation (NASDAQ: TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies. Financial and other details of the partnership were not disc
Twist Bioscience Stock Falls On Wider Q3 Loss, Sales Beat Estimates; Raises FY21 Guidance
03:34pm, Friday, 06'th Aug 2021
Twist Bioscience Corporation (NASDAQ: TWST) reported a 65% Y/Y increase in its third-quarter revenues to $35 million, beating the Wall Street estimate of $32.27 million, driven by strength in next-g
Twist Bioscience Corp. (TWST) CEO Emily Leproust on Q3 2021 Results - Earnings Call Transcript
03:13pm, Friday, 06'th Aug 2021
Twist Bioscience Corp. (TWST) CEO Emily Leproust on Q3 2021 Results - Earnings Call Transcript
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
10:44am, Friday, 06'th Aug 2021
Twist Bioscience (TWST) delivered earnings and revenue surprises of -7.89% and 7.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
07:35am, Friday, 06'th Aug 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
07:30am, Friday, 06'th Aug 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Forensic Value Stock Selections: Top Positive And Negative Scoring Stocks For Mid-Year 2021
12:26am, Tuesday, 06'th Jul 2021
Forensic Value Stock Selections: Top Positive And Negative Scoring Stocks For Mid-Year 2021
Twist Bioscience Scoops Up NGS Library Prep Tools Developer For $35M
11:21am, Wednesday, 30'th Jun 2021
Twist Bioscience Corporation (NASDAQ: TWST) has acquired iGenomX, a developer of multiplex library preparation tools for next-generation sequencing workflows, for $35 million. Twist said the acq
Twist Bioscience: Finding An Acceptable Valuation
06:39am, Monday, 28'th Jun 2021
Twist Bioscience has come across my desk several times over the past couple of years, but I have always found an excuse to push it to the side.
Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels
08:00am, Wednesday, 16'th Jun 2021
SCOTTS VALLEY, Calif., June 16, 2021 /PRNewswire/ -- Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced availability of its new line of capture
4 Unstoppable Healthcare Stocks to Buy on the Dip
06:05am, Wednesday, 26'th May 2021
They're well below peak levels set earlier this year. But they could be huge winners over the long run.
